Maximus, Inc. $MMS Stock: Reinhart Partners LLC. Lowers Stake

Key Points

• Reinhart Partners reduced its Maximus stake by 4.1%, selling 80,419 shares and retaining 1.90 million shares valued at approximately $101.2 million. Institutional investors collectively own 97.21% of the company.
• Analysts maintain a generally cautious view, with Maximus holding a consensus rating of “Hold.” Other funds, including Sound Income Strategies, GAMMA Investing, and Farther Finance Advisors, increased or initiated positions.
• Maximus reported quarterly EPS of $2.22, slightly above estimates, but revenue declined 5.1% year over year to $1.28 billion. The company also announced a quarterly dividend of $0.33 per share, equivalent to a 2.2% annual yield.

Reinhart Partners LLC. trimmed its stake in Maximus, Inc. (NYSE:MMS - Free Report) by 4.1% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 1,901,996 shares of the health services provider's stock after selling 80,419 shares during the quarter. Maximus makes up about 2.5% of Reinhart Partners LLC.'s investment portfolio, making the stock its 15th largest holding. Reinhart Partners LLC. owned about 3.63% of Maximus worth $101,167,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in MMS. Sound Income Strategies LLC bought a new position in shares of Maximus during the third quarter worth about $5,054,000. GAMMA Investing LLC lifted its position in Maximus by 254.5% in the 3rd quarter. GAMMA Investing LLC now owns 8,174 shares of the health services provider's stock valued at $435,000 after purchasing an additional 5,868 shares during the last quarter. Farther Finance Advisors LLC boosted its stake in Maximus by 469.6% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,743 shares of the health services provider's stock valued at $93,000 after purchasing an additional 1,437 shares during the period. Investors Research Corp acquired a new position in Maximus during the 3rd quarter valued at about $233,000. Finally, Sequoia Financial Advisors LLC bought a new position in Maximus in the 2nd quarter worth about $294,000. 97.21% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. Wall Street Zen lowered shares of Maximus from a "buy" rating to a "hold" rating in a research note on Saturday, August 8th. Weiss Ratings reiterated a "hold (c-)" rating on shares of Maximus in a research report on Monday, August 17th. Finally, Zacks Research raised Maximus from a "strong sell" rating to a "hold" rating in a report on Thursday, October 1st. Two investment analysts have rated the stock with a Hold rating. According to MarketBeat, the company presently has a consensus rating of "Hold".

Insider Activity at Maximus

In related news, insider Michelle Link sold 3,208 shares of the business's stock in a transaction that occurred on Thursday, October 1st. The shares were sold at an average price of $54.23, for a total value of $173,969.84. Following the sale, the insider directly owned 13,881 shares in the company, valued at $752,766.63. The trade was a 18.77% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.80% of the stock is owned by insiders.

Maximus Trading Up 1.0%

Shares of Maximus stock opened at $59.37 on Friday. The business has a fifty day simple moving average of $56.81 and a 200-day simple moving average of $59.82. Maximus, Inc. has a fifty-two week low of $51.04 and a fifty-two week high of $100.00. The firm has a market cap of $3.11 billion, a price-to-earnings ratio of 8.77 and a beta of 0.59. The company has a quick ratio of 2.42, a current ratio of 2.42 and a debt-to-equity ratio of 0.90.

Maximus (NYSE:MMS - Get Free Report) last released its earnings results on Thursday, August 6th. The health services provider reported $2.22 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.21 by $0.01. Maximus had a return on equity of 24.91% and a net margin of 7.07%. The firm had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same period in the previous year, the company earned $2.16 earnings per share. Maximus's revenue was down 5.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. On average, equities analysts forecast that Maximus, Inc. will post 8.03 EPS for the current fiscal year.

Maximus Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 30th. Stockholders of record on Friday, November 13th will be paid a $0.33 dividend. The ex-dividend date of this dividend is Friday, November 13th. This represents a $1.32 annualized dividend and a dividend yield of 2.2%. Maximus's payout ratio is currently 19.50%.

Maximus Company Profile

Maximus, Inc NYSE: MMS is a provider of government services and technology-enabled solutions. The company partners with federal, state, provincial and local governments to administer public programs, improve service delivery and support interactions between governments and the people they serve.

Its business activities include health and human services administration, employment and workforce services, child support and eligibility services, customer contact centers, program management, consulting and digital transformation.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.